An extension study of the LIBERTY 1 and 2 randomized controlled trials, LIBERTY 3, showed that the drug had efficacy through week 52, with no new safety signals.
Medscape Medical News
…read more
An extension study of the LIBERTY 1 and 2 randomized controlled trials, LIBERTY 3, showed that the drug had efficacy through week 52, with no new safety signals.
Medscape Medical News
…read more